HAMPS BIO LIMITED Share Price

HAMPS BIO LIMITED Share Price

BSE: 544312
|
Trading
|
S Cap
₹ 22.99
+₹2.02 (9.63%)
1D
Last updated 23 Sep, 2026, 12:11 IST

HAMPS BIO LIMITED Share Price Today

As of 23 Sep 2026, HAMPS BIO LIMITED share price is ₹22.99. The stock opened at ₹20.71, compared to its previous close of ₹20.97. During today's trading session, HAMPS BIO LIMITED share price moved in the range of ₹20.71 to ₹22.99, with an average price of ₹21.85 for the day. Looking at its last 52-week, the stock has touched a low of ₹13.36 and a high of ₹26.58.

₹20.71
9.63% up today
₹22.99
1D LOW
1D HIGH

HAMPS BIO LIMITED Returns Calculator

Circuit
L
H
₹18.88
₹23.06
52-week
L
H
₹13.36
₹26.58

About HAMPS BIO LIMITED

HAMPS BIO LIMITED Share Price
ISIN
INE0QBD01018
Sector Market Cap
₹ 19.99 Cr

Hamps Bio Limited is an India-based company, which is engaged in pharmaceutical formulation and freeze-drying ingredient manufacturing and distributing. Its products include home pharmaceutical products and freeze-drying food products. Its home pharmaceutical products include antibiotic/antibacterial/antifungal; hematantic/calcium supplement; painkiller/ anti-inflammatory; antiacid/PPI; mouth wash; toothpaste; pediatric care; nutrition supplement, and injections. Its freeze-drying food products include ingredients for fruit tea / traditional tea; ingredients for fruit snacks / juice powder/ smoothie mix / ice cream; ingredients for noodles / instant food / ready to eat; ingredients for super food, and application like camel milk / curd / panner/ cheese / cow colostrum. Its injection products include ALLSEF; Beep 40; BMXCLAV; PTSEFT; SEFTZONE-1.5GM, and others. Its ingredients for super food include prickly pear, beet, spinach, noni, garcinia cambochia, and more.

HAMPS BIO LIMITED Financial Highlights

  • Revenue: HAMPS BIO LIMITED reported revenue of ₹8.80 crore in FY26 vs ₹6.82 crore in FY25. It showed an increase of 29.03% on a yearly basis.
  • Operating Profit: HAMPS BIO LIMITED reported an operating loss of ₹0.70 crore in FY26 vs ₹0.40 crore in FY25. It showed a decrease of 275.00% on a year-on-year basis.
  • Net Profit: HAMPS BIO LIMITED reported a net loss of ₹0.74 crore in FY26 vs ₹0.30 crore in FY25. It showed a decrease of 346.67% on a yearly basis.
Know more
Promoters
71.99%
FII
0.00%
Other DII
0.00%
Retail and other
28.01%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Mar 20250.00%
Jun 20250.00%
Sep 20250.00%
Mar 20260.00%
Mkt Cap Cr
0.00
P/E
0.00
P/B
1.78
ROE
0.00%
D/E
0.78
ROCE
0.00%
Div. Yield
0.00%
EPS(TTM)
-0.75
Turnover
0.71
EV/EBITDA
57.24
Net Margin
-7.63%
Op. Margin
5.16%
ROA
-4.90%
Quick Ratio
0.69
Curr. Ratio
8.60
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Hamps Bio has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Hamps Bio appears overvalued compared to its peers
Step 2 of 5
Earnings
Poor
Hamps Bio earnings have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,00,364.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

HAMPS BIO LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Revenue₹8.47₹6.67
Other Income₹0.33₹0.15
Total Revenue₹8.81₹6.82
Total Expenses₹9.51₹6.42
Profit Before Tax-₹0.70₹0.40
Tax₹0.04₹0.11
Profit After Tax-₹0.74₹0.30
EPS - Basic-₹0.85₹0.34
EPS - Diluted-₹0.85₹0.34

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Profit before tax-₹0.74₹0.30
Income before WC changes₹0.30-₹0.19
Change in Assets-₹0.92-₹1.77
Change in Liabilities-₹0.09₹0.30
Change in WC-₹1.01-₹1.47
Cash flow from Operations-₹0.71-₹1.76
Cash flow from Investing-₹2.93-₹6.21
Cash flow from Financing₹3.72₹8.00
Total Cash Flow₹0.07₹0.04
Cash (Start of the year)₹0.10₹0.06
Cash (End of the year)₹0.17₹0.10

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Non-Current Assets₹10.62₹8.49
Current Assets₹5.30₹4.31
Total Assets₹15.92₹12.79
Current Liabilities₹3.62₹1.87
Net Current Asset₹1.68₹2.43
Non-Current Liabilities₹4.20₹2.12
Equity Capital₹8.10₹8.80
Total Equity & Liabilities₹15.92₹12.79

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹8.52₹6.67₹6.48₹5.58
Other Income₹0.33₹0.15₹0.03₹0.01
Total Revenue₹8.85₹6.82₹6.50₹5.58
Total Expenses₹9.47₹6.42₹5.85₹5.23
Profit Before Tax-₹0.62₹0.40₹0.65₹0.36
Tax₹0.04₹0.11₹0.15₹0.00
Profit After Tax-₹0.65₹0.30₹0.50₹0.36
EPS - Basic-₹0.75₹0.34₹2.55₹1.34
EPS - Diluted-₹0.75₹0.34₹2.55₹1.34

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹0.65₹0.30₹0.50₹0.36
Income before WC changes₹0.39-₹0.19₹1.15₹0.87
Change in Assets-₹0.37-₹1.77-₹1.21₹0.10
Change in Liabilities-₹0.39₹0.30-₹0.08₹0.26
Change in WC-₹0.76-₹1.47-₹1.29₹0.36
Cash flow from Operations-₹0.37-₹1.76-₹0.29₹1.23
Cash flow from Investing-₹2.93-₹6.21-₹0.37-₹0.75
Cash flow from Financing₹3.23₹8.00₹0.67-₹0.48
Total Cash Flow-₹0.06₹0.04₹0.01₹0.00
Cash (Start of the year)₹0.10₹0.06₹0.05₹0.05
Cash (End of the year)₹0.03₹0.10₹0.06₹0.05

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹10.61₹8.49₹2.68₹2.73
Current Assets₹4.62₹4.31₹2.44₹1.23
Total Assets₹15.22₹12.79₹5.12₹3.96
Current Liabilities₹3.17₹1.87₹1.40₹2.07
Net Current Asset₹1.44₹2.43₹1.03-₹0.84
Non-Current Liabilities₹3.87₹2.12₹0.37₹0.52
Equity Capital₹8.18₹8.80₹3.34₹1.36
Total Equity & Liabilities₹15.22₹12.79₹5.12₹3.96
* All values are in INR Crore
Qty
Bid
4000
20.01
4000
20
4000
19.4
8000
19.39
4000
19.05
Ask
Qty
23.05
4000
0
0
0
0
0
0
0
0
Bid Total: 24000
Ask Total: 4000
Buy orders: 86%
Sell orders: 14%
Bearish
2
Neutral
3
Bullish
3
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
38.24
Neutral
ATR (14)
1.83
Neutral
STOCH(9,6)
5.1
Bullish
STOCH RSI (14)
1.68
Bullish
ADX(9)
31.09
Bearish
UO(9)
46.27
Neutral
ROC(12)
-13.49
Bearish
WillR(14)
-94.9
Bullish
Period
Simple value
Exponential vaue
5D
24.24
23.26
10D
23.82
23.83
20D
24.33
24.26
50D
25.11
24.13
100D
22.36
25.04
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
17 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
HAMPS BIO LIMITED Share Price
HAMPS BIO LIMITED
Trading
Add Stock
Add Another

HAMPS BIO LIMITED Share Price FAQs

HAMPS BIO LIMITED share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837